Home>Topics>Companies>Schering-Plough

Schering-Plough MRK

  1. All
  2. Commentary
  3. Headlines
    1. Merck and Ranbaxy settle Medicaid suits

      Headlines

      Thu, 16 Oct 2014

      Without admitting to any wrongdoing, Merck 's ( MRK -2% ) Organon unit agrees to ..... promoted it for non-approved indications. Merck acquired Organon as part of its takeover of Schering - Plough in 2009. Indian generic firm Ranbaxy Laboratories

    2. BRIEF-Vastned Retail places 75 mln euro long-term loan

      Headlines

      Thu, 25 Sep 2014

      * Places 75 million euro long-term loan with Axa Real Estate Investment Managers SGP acting on behalf of its clients Source text: http://bit.ly/1Dy32iA Further company coverage: (Gdynia Newsroom: +48 58 698 39 20; Gdynia.newsroom@thomsonreuters.com)

    3. ‘Trying to Recapture the Magic’: The Strategy Behind the Pharma M&A Rush

      Headlines

      Fri, 30 May 2014

      background or infrastructure. Merck came to own the consumer products ..... after its 2009 acquisition of Schering - Plough . Back then, Merck faced patent expirations on major ..... asthma drug Singulair — and Schering - Plough had a relatively stronger branded

    4. High-Priced Sale of Consumer Business Strengthens This Big Pharma Firm's Moat

      Headlines

      Wed, 7 May 2014

      bottom line, Merck has been cutting ..... merger with Schering - Plough , which Merck ..... Standard, as Merck has shown reasonable ..... purchase of Schering - Plough at a fair price ..... Further, Merck 's acquisition of Schering - Plough should yield

    5. Stockland Bolsters Balance Sheet Before Escalating Investment in Retail

      Commentary

      Wed, 22 May 2013

      Stockland SGP raised AUD 400 million of additional equity via an institutional placement at AUD 3.88 per security, representing a 2.5

    6. Stockland's Revised Strategy Sees Rebirth of Industrial

      Commentary

      Wed, 15 May 2013

      At the third-quarter update Stockland SGP guided fiscal 2013 earnings per share (EPS) to be down 25% on fiscal 2012. The downgrade to prior guidance for EPS to fall

    7. Stockland's Residential Impairment Overshadows Resilient Commercial Property Result in First Half

      Commentary

      Wed, 13 Feb 2013

      Stockland's SGP first-half fiscal 2013 normalised operating profit fell by 28% to AUD 255 million, largely due to a change to accounting treatment of interest capitalised into residential development. Stockland also impaired inventory held on balance sheet, resulting in a AUD 318 million writedown ...

    8. Lower Developer Margins Expected for Stockland Following Review of Capitalised Interest

      Commentary

      Tue, 22 Jan 2013

      Stockland SGP is undertaking a review of its capitalised interest policy following an escalation in the level of capitalised interest on the

    9. What Next For The Euro-Zone?

      Headlines

      Fri, 6 Jul 2012

      approved the Stability and Growth Pact ( SGP ) in 1997. This called for fiscal monitoring by ..... behind Maastricht and especially behind the SGP was “don’t saddle the prudent members with ..... Meanwhile, it quickly became apparent that the SGP was unenforceable – largely because the

    10. Merck Reports Strong 3Q Driven by Growth Across Product Portfolio and Lower R&D Costs

      Commentary

      Fri, 28 Oct 2011

      costs helped fuel growth. Merck raised the lower end of ..... across the majority of Merck 's products supported ..... Beyond 2012, we expect Merck to return to growth as ..... cost synergies from the Schering - Plough acquisition. We expect

    « Prev12345Next »
    Content Partners